Lactoferrin
Also sold as: Bovine lactoferrin · Apo-lactoferrin · Milk iron-binding protein
An iron-binding milk protein studied mainly in iron-deficiency anemia and as an adjunct to selected infection treatments. General gut repair and rapid calming claims outrun the clinical evidence.
Energy
Community
Not enough ratings yet: 0 of 10
Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.
Research
- Energy: General energy enhancement is unestablished; anemia treatment findings cannot be generalized to iron-replete adults. This is an evidence gap, not a negative energy RCT.
REALITY CHECK // Anemia is the strongest clinical context, with tolerability often better than ferrous sulfate; this does not prove a general energy or immunity boost. Large neonatal results conflict with early positive trials, and adult gut outcomes remain preliminary. No human RCT evidence in this dossier supports a rapid sedative effect.
Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.
Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.
Check your bottle
Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.
Enter the amount from your label to see the result.
How it was studied
UPPER LIMIT // No EFSA or NIH tolerable upper intake level is established in the dossier. Studied tolerability up to 3 g/day does not establish long-term safety or an individual safe ceiling.
Summary
Bovine lactoferrin trials and reviews suggest improvement in iron-deficiency anemia with fewer gastrointestinal complaints than ferrous sulfate, but heterogeneous small studies do not establish universal superiority or formal non-inferiority. Neonatal sepsis findings conflict: early positive studies were not confirmed by the large ELFIN trial.
Mechanism
Binds iron and can influence iron availability, inflammatory signaling and microbial ecology. Mechanisms do not establish mood benefits or a clinical gut-repair effect.
Typical studied dose
Adult anemia studies described in the dossier used 100–250 mg/day for about 4–8 weeks. Other research used 100 mg–3 g/day; those heterogeneous amounts are not a universal recommended range or a safety ceiling.
Upper limit
No EFSA or NIH tolerable upper intake level is established in the dossier. Studied tolerability up to 3 g/day does not establish long-term safety or an individual safe ceiling.
Popular stacks with Lactoferrin
Not enough stack data yet. A combination with Lactoferrin appears here once 5 people rate the same set.
Forms and label traps
| Form on label | Active content | Studied range / day | Absorption & GI tolerance | Verdict |
|---|---|---|---|---|
| Native bovine lactoferrin Best for: Match bovine protein identity and declared lactoferrin mass to the anemia research context. |
Extract weight · marker not quantified | 100–250 mg | Most adult anemia evidence concerns bovine lactoferrin; commercial preparations may differ. Often fewer GI complaints than ferrous sulfate in anemia comparisons. |
Studied standard [FORM // TRIAL_CONTEXT] Compare full lactoferrin protein mass, not iron saturation. Native iron saturation around 15–20% describes binding-site occupancy, not 15–20% elemental iron by mass. |
| Apo-lactoferrin Best for: Identify low iron-saturation protein explicitly. |
Unstandardized: active content unknown | no comparable trial range | An isotope study in Kenyan infants found greater tracer iron absorption than with holo-lactoferrin; adult benefit is uncertain. Digestive tolerance varies; stop for persistent symptoms. |
Caution [FORM // NO_VALIDATED_RANGE] Unknown adult apo-specific trial interval. Near-zero iron occupancy is not a dose-conversion factor. |
| Holo-lactoferrin Best for: Check measured iron per serving if iron exposure matters. |
Unstandardized: active content unknown | no comparable trial range | Infant isotope iron absorption was similar to ferrous sulfate; this is not adult clinical superiority. Digestive tolerance varies; stop for persistent symptoms. |
Caution [FORM // NO_VALIDATED_RANGE] 100% occupied binding sites does not mean 100% elemental iron by weight. No conversion to iron is performed. |
Common label traps
- TRAP_01 // INSTANT CALM LIKE A SEDATIVE
There is no supporting human anxiety RCT in this dossier. - TRAP_02 // SIDE EFFECTS PROVE DIE-OFF
Cramps or headache do not establish microbial killing; assess tolerability and stop signals. - TRAP_03 // APO OR HOLO IS ALWAYS SUPERIOR
The cited form comparison measured iron absorption in infants, not adult mood, immunity or long-term anemia superiority.
Other outcomes studied
Outside the five leaderboard goals. Same evidence levels as above.
- IRON-DEFICIENCY ANEMIA Moderate · benefit
Clinical reviews report improved hemoglobin and ferritin with better GI tolerability than ferrous sulfate in some comparisons; no significant difference is not proof of equivalence. Pregnant and nonpregnant women and dialysis populations differ.
PMID 35276902 PMID 29059584 PMID 42302886 PMID 38231718 - PEDIATRIC ANEMIA Limited · benefit
Small IBD and cerebral-palsy trials are promising, but a systematic review describes heterogeneous, limited pediatric evidence; adult doses do not transfer.
PMID 35681097 PMID 34101010 PMID 37661669 - H. PYLORI ADJUNCT Limited · benefit
Older meta-analyses favor bovine lactoferrin added to standard therapy; recombinant human lactoferrin was ineffective as treatment.
PMID 19183156 PMID 19298339 PMID 12492741 - PRETERM SEPSIS / NEC Limited · no benefit
Early positive pooled results conflict with the roughly2200-infant ELFIN null infection result; the dossier describes updated pooled conclusions as uncertain. This hospital population is unrelated to adult supplement claims.
PMID 30635141 PMID 32232984 PMID 37782505 - ACNE Limited · benefit
Small trials of lactoferrin plus vitamin E/zinc or enriched fermented milk suggest improvement over8–12 weeks; effects cannot be isolated to lactoferrin.
PMID 28369875 PMID 20692602 - RESPIRATORY INFECTIONS / IMMUNITY Limited · benefit
Mixed-population pooled data are heterogeneous and low-to-moderate quality; modest immune findings in a healthy-adult trial do not justify a broad immunity promise.
PMID 35481594 PMID 39465888 - MICROBIOME / INFLAMMATION Limited · benefit
A microencapsulated bovine pilot and an HIV/ART recombinant-human study concern biomarkers and selected populations, not established gut disease treatment.
PMID 30126153 PMID 30721997
Reader questions
Should I take it fasting or with food?
Anemia research used100–250 mg/day, but a universal fasting advantage is unestablished. Food may improve personal tolerance; match the clinician-selected product and indication.
Will it keep ferritin up when ordinary iron did not?
The studies do not guarantee durable correction. Persistent or recurrent deficiency needs evaluation of blood loss, absorption and the original diagnosis.
Does a metallic taste mean it is working?
No. It can be a tolerability symptom or relate to other ingredients. Stop and seek advice for persistent symptoms; allergic symptoms require urgent evaluation.
Can it help acne?
Small combination-product and enriched-milk trials give a limited signal; they do not establish the effect of plain lactoferrin alone.
Stack interactions
- Caution Levothyroxine and iron-containing products [CAUTION // CLINICAL_CONTEXT]
A label-declared iron component can impair thyroid-drug absorption. The dossier suggests at least four hours of separation for iron; confirm the actual combination with a pharmacist. Direct lactoferrin interaction evidence is absent. - Caution H. pylori antibiotic/PPI regimens [CAUTION // CLINICAL_CONTEXT]
Older meta-analyses found bovine lactoferrin useful as an adjunct, not a replacement for eradication therapy. Separate iron-containing formulations from susceptible antibiotics according to drug instructions.
PMID 19183156 PMID 19298339 - Caution Additional oral iron [CAUTION // CLINICAL_CONTEXT]
Do not infer iron content from apo/holo saturation. Sum actual label-declared iron and review combined treatment in iron overload or anemia.
Red flags: interactions and who should avoid it
Interactions
Review additional iron and actual label-declared iron content. Iron-containing combinations may affect levothyroxine and tetracycline/quinolone absorption; the concern is iron, not a proven lactoferrin-specific interaction. Bovine lactoferrin has also been studied with antibiotics and acid suppression for H. pylori.
Avoid or ask a doctor first if
Avoid bovine products with cow-milk protein allergy. Iron overload, pregnancy, breastfeeding and anemia management require professional review. Persistent cramps, diarrhea, headache or a metallic taste should not be relabeled as detoxification.
Sources (PubMed, 14)
- Comparative Effects between Oral Lactoferrin and Ferrous Sulfate Supplementation on Iron-Deficiency Anemia: A Comprehensive Review and Meta-Analysis of Clinical Trials.
PMID 35276902 · 2022 · systematic review / meta-analysisAnemia comparative review; tolerability advantage does not establish universal efficacy superiority.
- Lactoferrin or ferrous salts for iron deficiency anemia in pregnancy: A meta-analysis of randomized trials.
PMID 29059584 · 2017 · systematic review / meta-analysisPregnancy anemia comparison with ferrous salts.
- Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial.
PMID 30635141 · 2019 · randomized controlled trialLarge placebo-controlled preterm-infant trial did not confirm an infection benefit.
- Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.
PMID 32232984 · 2020 · systematic review / meta-analysisUpdated neonatal prevention synthesis; interpret alongside ELFIN.
- A randomized, double-blind, placebo-controlled trial to determine the efficacy and safety of lactoferrin with vitamin E and zinc as an oral therapy for mild to moderate acne vulgaris.
PMID 28369875 · 2017 · randomized controlled trialAcne result from lactoferrin combined with vitamin E and zinc.
- Dietary effect of lactoferrin-enriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris.
PMID 20692602 · 2010 · randomized controlled trialAcne trial of enriched fermented milk, not isolated protein.
- Effect of Lactoferrin Supplementation on Inflammation, Immune Function, and Prevention of Respiratory Tract Infections in Humans: A Systematic Review and Meta-analysis.
PMID 35481594 · 2022 · systematic review / meta-analysisHeterogeneous human immune and respiratory-infection evidence.
- A Randomized, Double-Blind, Controlled Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Immunological and Safety Parameters in Healthy Adults.
PMID 39465888 · 2025 · randomized controlled trialHealthy-adult immunological and safety study.
- Bioavailability of a Novel Form of Microencapsulated Bovine Lactoferrin and Its Effect on Inflammatory Markers and the Gut Microbiome: A Pilot Study.
PMID 30126153 · 2018 · randomized controlled trialPilot microencapsulated protein, microbiome and inflammatory markers.
- The Effects of Recombinant Human Lactoferrin on Immune Activation and the Intestinal Microbiome Among Persons Living with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy.
PMID 30721997 · 2019 · randomized controlled trialRecombinant-human protein studied in HIV patients receiving ART.
- Iron Absorption is Greater from Apo-Lactoferrin and is Similar Between Holo-Lactoferrin and Ferrous Sulfate: Stable Iron Isotope Studies in Kenyan Infants.
PMID 32886113 · 2020 · randomized controlled trialInfant isotope absorption comparison of apo and holo protein.
- Human recombinant lactoferrin is ineffective in the treatment of human Helicobacter pylori infection.
PMID 12492741 · 2003 · clinical study / reportNegative recombinant-human lactoferrin H. pylori treatment study.
- Meta-analysis: efficacy of bovine lactoferrin in Helicobacter pylori eradication.
PMID 19183156 · 2009 · systematic review / meta-analysisBovine lactoferrin adjunct to H. pylori eradication.
- Lactoferrin as treatment for iron-deficiency anemia in children: a systematic review.
PMID 37661669 · 2023 · systematic review / meta-analysisLimited and heterogeneous pediatric anemia evidence.
Community comments
No approved comments yet. Comments are held for moderation.